Literature DB >> 15760081

Transdermal delivery of zidovudine (AZT): the effects of vehicles, enhancers, and polymer membranes on permeation across cadaver pig skin.

Nuntakan Suwanpidokkul1, Phensri Thongnopnua, Kaisri Umprayn.   

Abstract

The purpose of this study was to investigate the effects of vehicles, enhancers, and polymer membranes on 3'-azido-3'-deoxythymidine (AZT) permeation across cadaver pig skin. Four binary vehicles (ethanol/water, isopropyl alcohol/water, polyethylene glycol 400/water, and ethanol/isopropyl myristate [IPM]) were tested for AZT solubility and permeability across pig skin; ethanol/IPM (50/50, vol/vol) demonstrated the highest AZT flux (185.23 microg/cm2/h). Next, the addition of various concentrations of different enhancers (N-methyl-2-pyrrolidone [NMP], oleic acid, and lauric acid) to different volume ratios of ethanol/IPM was investigated for their effect on AZT solubility and permeability across pig skin. The use of 2 combinations (ethanol/IPM [20/80] plus 10% NMP and ethanol/IPM [30/70] plus 10% NMP) resulted in increased AZT solubility (42.6 and 56.27 mg/mL, respectively) and also high AZT flux values (284.92 and 460.34 microg/cm2/h, respectively) without appreciable changes in lag times (6.25 and 7.49 hours, respectively) when compared with formulations using only ethanol/IPM at 20/80 and 30/70 volume ratios without addition of the enhancer NMP. Finally, AZT permeation across pig skin covered with a microporous polyethylene (PE) membrane was investigated. The addition of the PE membrane to the pig skin reduced AZT flux values to 50% of that seen with pig skin alone. However, the AZT flux value attained with ethanol/IPM (30/70) plus 10% NMP was 215.31 microg/cm2/h, which was greater than the target flux (208 mug/cm2/h) needed to maintain the steady-state plasma concentration in humans. The results obtained from this study will be helpful in the development of an AZT transdermal drug delivery system.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15760081      PMCID: PMC2750270          DOI: 10.1208/pt050348

Source DB:  PubMed          Journal:  AAPS PharmSciTech        ISSN: 1530-9932            Impact factor:   3.246


  15 in total

Review 1.  Novel mechanisms and devices to enable successful transdermal drug delivery.

Authors:  B W Barry
Journal:  Eur J Pharm Sci       Date:  2001-09       Impact factor: 4.384

2.  Enhanced delivery of zidovudine through rat and human skin via ester prodrugs.

Authors:  T Seki; T Kawaguchi; K Juni
Journal:  Pharm Res       Date:  1990-09       Impact factor: 4.200

3.  Effects of freezing on human skin permeability.

Authors:  S M Harrison; B W Barry; P H Dugard
Journal:  J Pharm Pharmacol       Date:  1984-04       Impact factor: 3.765

Review 4.  Safety and tolerance of dideoxycytidine as a single agent. Results of early-phase studies in patients with acquired immunodeficiency syndrome (AIDS) or advanced AIDS-related complex. Study Group of the AIDS Clinical Trials Group of the National Institute of Allergy and Infectious Diseases.

Authors:  T C Merigan; G Skowron
Journal:  Am J Med       Date:  1990-05-21       Impact factor: 4.965

5.  Effect of application volume of ethanol-isopropyl myristate mixed solvent system on permeation of zidovudine and probenecid through rat skin.

Authors:  Y Jin; T Seki; Y Morimoto; K Juni
Journal:  Drug Dev Ind Pharm       Date:  2000-02       Impact factor: 3.225

6.  Hairless mouse skin is limited as a model for assessing the effects of penetration enhancers in human skin.

Authors:  J R Bond; B W Barry
Journal:  J Invest Dermatol       Date:  1988-06       Impact factor: 8.551

7.  Plasma and cerebrospinal fluid pharmacokinetics of 3'-azido-3'-deoxythymidine: a novel pyrimidine analog with potential application for the treatment of patients with AIDS and related diseases.

Authors:  R W Klecker; J M Collins; R Yarchoan; R Thomas; J F Jenkins; S Broder; C E Myers
Journal:  Clin Pharmacol Ther       Date:  1987-04       Impact factor: 6.875

8.  Transdermal delivery of zidovudine: effect of vehicles on permeation across rat skin and their mechanism of action.

Authors:  Narisetty Sunil Thomas; Ramesh Panchagnula
Journal:  Eur J Pharm Sci       Date:  2003-01       Impact factor: 4.384

9.  Transdermal delivery of dideoxynucleoside-type anti-HIV drugs. 2. The effect of vehicle and enhancer on skin permeation.

Authors:  D D Kim; Y W Chien
Journal:  J Pharm Sci       Date:  1996-02       Impact factor: 3.534

10.  Passive and iontophoretic transport enhancement of insulin through porcine epidermis by depilatories: permeability and fourier transform infrared spectroscopy studies.

Authors:  Sumeet K Rastogi; Jagdish Singh
Journal:  AAPS PharmSciTech       Date:  2003       Impact factor: 3.246

View more
  10 in total

1.  Feasibility of transdermal delivery of fluoxetine.

Authors:  Darshan K Parikh; Tapash K Ghosh
Journal:  AAPS PharmSciTech       Date:  2005-09-30       Impact factor: 3.246

2.  Optimization of hydrogels for transdermal delivery of lisinopril by Box-Behnken statistical design.

Authors:  Ramesh Gannu; Vamshi Vishnu Yamsani; Shravan Kumar Yamsani; Chinna Reddy Palem; Madhusudan Rao Yamsani
Journal:  AAPS PharmSciTech       Date:  2009-04-28       Impact factor: 3.246

3.  Influence of the Component Excipients on the Quality and Functionality of a Transdermal Film Formulation.

Authors:  Suprit D Saoji; Sandip C Atram; Pradip W Dhore; Priya S Deole; Nishikant A Raut; Vivek S Dave
Journal:  AAPS PharmSciTech       Date:  2015-04-29       Impact factor: 3.246

4.  Transdermal permeation of Kaempferia parviflora methoxyflavones from isopropyl myristate-based vehicles.

Authors:  Sarunya Tuntiyasawasdikul; Ekapol Limpongsa; Napaphak Jaipakdee; Bungorn Sripanidkulchai
Journal:  AAPS PharmSciTech       Date:  2014-05-03       Impact factor: 3.246

5.  Evaluation of glycofurol-based gel as a new vehicle for topical application of naproxen.

Authors:  Nahla Salah Barakat
Journal:  AAPS PharmSciTech       Date:  2010-07-23       Impact factor: 3.246

6.  Iontophoretic permeation of lisinopril at different current densities and drug concentrations.

Authors:  Ashish Jain; Satish Nayak; Vandana Soni
Journal:  Adv Pharm Bull       Date:  2012-08-15

Review 7.  Current and emerging formulation strategies for the effective transdermal delivery of HIV inhibitors.

Authors:  Anthony S Ham; Robert W Buckheit
Journal:  Ther Deliv       Date:  2015-02

8.  Screening of venlafaxine hydrochloride for transdermal delivery: passive diffusion and iontophoresis.

Authors:  Gursharanjit Singh; Bijaya Ghosh; Dave Kaushalkumar; Vanita Somsekhar
Journal:  AAPS PharmSciTech       Date:  2008-07-01       Impact factor: 3.246

9.  Transdermal delivery of venlafaxine hydrochloride: the effects of enhancers on permeation across pig ear skin.

Authors:  C Vijaya; Manasa Bingi; L V Vigneshwaran
Journal:  Indian J Pharm Sci       Date:  2011-07       Impact factor: 0.975

10.  Enhancement of the transdermal delivery of zidovudine by pretreating the skin with two physical enhancers: microneedles and sonophoresis.

Authors:  Irene de Jesús Martínez-Segoviano; Adriana Ganem-Rondero
Journal:  Daru       Date:  2021-07-03       Impact factor: 4.088

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.